Trignano Emilio, Baccari Manuel, Pili Nicola, Serra Pietro Luciano, Rubino Corrado
Plastic Surgery Unit, Department of Medical, Surgical and Experimental Sciences, Sassari University Hospital Trust, University of Sassari, Sassari, Italy.
Gland Surg. 2020 Dec;9(6):2193-2197. doi: 10.21037/gs-20-448.
Breast augmentation is a very requested procedure in aesthetic surgery. Over time, various techniques of breast augmentation have been described, both through the use of alloplastic materials and autologous tissues: implants, fat grafting, flap surgery, and injectable fillers. According to the international current trend to perform minimally invasive procedure, injectable fillers have progressively increased their uses and notoriety in aesthetic medicine. Among the various available products, hyaluronic acid is likely to be the most popular synthetic filler all over the world. Nowadays many brands are on the market and this paper focuses on Macrolane which is a NASHA-based (stabilized hyaluronic acid of non-animal origin) filler. However, although highly biocompatible, as any material, foreign to our body, also hyaluronic acid fillers undergo a process of degradation and disposal. In our work, we report the first case in literature of migration of Macrolane in an axillary lymph node in a 45-year-old woman three years after injection for breast augmentation and its related management. The aim of the paper is to discuss and underline further complications and their treatment besides the ones already described in literature in order to provide a deeper knowledge concerning the use and the side effects of injectable fillers in aesthetic medicine.
隆胸手术是美容外科中一项备受需求的手术。随着时间的推移,人们描述了多种隆胸技术,包括使用异体材料和自体组织:植入物、脂肪移植、皮瓣手术和可注射填充剂。根据当前国际上进行微创手术的趋势,可注射填充剂在美容医学中的应用和知名度逐渐增加。在各种可用产品中,透明质酸可能是全球最受欢迎的合成填充剂。如今市场上有许多品牌,本文重点介绍了麦罗莲,它是一种基于NASHA(非动物源性稳定透明质酸)的填充剂。然而,尽管具有高度生物相容性,但作为任何与我们身体不同的材料,透明质酸填充剂也会经历降解和清除过程。在我们的研究中,我们报告了文献中首例在一名45岁女性隆胸注射三年后,麦罗莲迁移至腋窝淋巴结的病例及其相关处理。本文的目的是除了文献中已描述的并发症外,讨论并强调进一步的并发症及其治疗方法,以便更深入地了解美容医学中可注射填充剂的使用和副作用。